The Patent Finder

Aardvark Therapeutics Inc.

21 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

0
Ending by 2030
Nov 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Feb 6 to 15, 2027 · next Feb 6
  • 1 fee due May 12, 2027
    The maintenance fee for Abuse Deterrent Formulations of Amphetamine (US 10,471,015) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,663,484Isoflavonoid compounds and methods for the treatment of cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,708,283Isoflavonoid compositions and methods for the treatment of cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,981,936Isoflavonoid compositions and methods for the treatment of cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,105,346Isoflavonoid compounds and methods for the treatment of cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,369,132Isoflavonoid compositions and methods for the treatment of cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,973,799Isoflavonoid compositions and methods for the treatment of cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,583,514Isoflavonoid compounds and methods for the treatment of cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,723,893Isoflavonoid compositions and methods for the treatment of cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,318,364Isoflavonoid compositions and methods for the treatment of cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,329,739Isoflavonoid compounds and methods for the treatment of cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 21 patents shown.
Pro members see all 21.
Pro members: see all 21 patents
Also on record, not counted in the 21: 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 1 abandoned · 3 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited